Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...

CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...

The development of gene editing tools, which enable the specific targeting and correction of mutations, hold the promise of allowing us to correct those mutations that cause genetic diseases. However, ...

At the heart of this technology is the Cas9 protein, often likened to molecular scissors, capable of cutting strands of DNA at specific locations dictated by a single guide RNA. With this mechanism, ...

Researchers have successfully develop single-atom editing technology that maximizes drug efficacy. In pioneering drug development, the new technology that enables the easy and rapid editing of key ...

Researchers have developed a novel generative AI model, called Collaborative Competitive Agents (CCA), that significantly ...

While researchers have long appreciated the enormous potential of genome editing to treat disease, applications of these technologies in humans have historically been limited by safety concerns. Even ...

A team of Chinese scientists has used gene therapy to correct a mutation that caused mice to exhibit autistic behaviors like hyperactivity, repetitive self-grooming, and abnormal social interactions.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

Joint Statement by Ralph J. Cicerone and Victor J. Dzau WASHINGTON -- The National Academy of Sciences and the National Academy of Medicine are launching a major initiative to guide decision making ...